Edwards Lifesciences
EW
NYSE
IPO2000
about EW
Edwards Lifesciences is a global leader in developing and marketing innovative medical devices, particularly focused on cardiovascular care, including advanced heart valve technologies and minimally invasive solutions to improve patient outcomes.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $83.09 | $83.68 | $81.92 | $48.5B | 1.53M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$0.50 | 12.07 | 30.95 | 19.77% | 18.69% | 0% |